KAL1 Antikörper (AA 548-657)
(1 reference)-
- Target Alle KAL1 Antikörper anzeigen
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
-
Bindungsspezifität
- AA 548-657
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser KAL1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant KAL1.
- Sequenz
- LAKPENLSAS FIVQDVNITG HFSWKMAKAN LYQPMTGFQV TWAEVTTESR QNSLPNSIIS QSQILPSDHY VLTVPNLRPS TLYRLEVQVL TPGGEGPATI KTFRTPELPP
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- KAL1 (NP_000207, 548 a.a. ~ 657 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 2E8
- Isotyp
- IgG2a
- Top Product
- Discover our top product KAL1 Primärantikörper
-
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 200-300) antibody
KAL1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) antibodyKAL1 Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 166-194), (N-Term) antibodyKAL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB39497 unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (Internal Region) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis." in: Journal of dermatological science, Vol. 58, Issue 1, pp. 64-71, (2010) (PubMed).
-
: "Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis." in: Journal of dermatological science, Vol. 58, Issue 1, pp. 64-71, (2010) (PubMed).
-
- Target
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
- Andere Bezeichnung
- KAL1 (KAL1 Produkte)
- Synonyme
- ADMLX antikoerper, HH1 antikoerper, HHA antikoerper, KAL antikoerper, KALIG-1 antikoerper, KMS antikoerper, WFDC19 antikoerper, KAL1 antikoerper, hha antikoerper, kal antikoerper, kms antikoerper, admlx antikoerper, kalig-1 antikoerper, anosmin-1a antikoerper, kal1.1 antikoerper, kal1a antikoerper, wu:fl91z45 antikoerper, anosmin 1 antikoerper, anosmin 1a antikoerper, ANOS1 antikoerper, anos1 antikoerper, anos1a antikoerper
- Hintergrund
-
Full Gene Name: Kallmann syndrome 1 sequence
Synonyms: ADMLX,HHA,KAL,KALIG-1,KMS - Gen-ID
- 3730
- NCBI Accession
- NM_000216
-
